Late Breaking Abstract - Anaplastic Lymphoma Kinase inhibition as an effective treatment strategy against the enhanced lung carcinogenesis and cancer angiogenesis related to decreased PTPRZ1 expression

D. Ntenekou (Patras, Greece), P. Kastana (Patras, Greece), M. Hatziapostolou (Nottingham, United Kingdom), C. Polytarchou (Nottingham, United Kingdom), A. Marazioti (Patras, Greece), S. Nikou (Patras, Greece), G. Herradon (Madrid, Spain), E. Papadaki (Patras, Greece), G. Stathopoulos (Patras, Greece), C. Mikelis (Amarillo, TX, United States of America), E. Papadimitriou (Patras, Greece)

Source: Virtual Congress 2020 – Biological aspects of lung cancer

Session: Biological aspects of lung cancer
Session type: Oral Presentation
Number: 3939

Disease area: Thoracic oncology

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Ntenekou (Patras, Greece), P. Kastana (Patras, Greece), M. Hatziapostolou (Nottingham, United Kingdom), C. Polytarchou (Nottingham, United Kingdom), A. Marazioti (Patras, Greece), S. Nikou (Patras, Greece), G. Herradon (Madrid, Spain), E. Papadaki (Patras, Greece), G. Stathopoulos (Patras, Greece), C. Mikelis (Amarillo, TX, United States of America), E. Papadimitriou (Patras, Greece). Late Breaking Abstract - Anaplastic Lymphoma Kinase inhibition as an effective treatment strategy against the enhanced lung carcinogenesis and cancer angiogenesis related to decreased PTPRZ1 expression. 3939

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Met amplification induces an aggressive phenotype in EGFR tyrosine kinase inhibitors resistant non-small-cell lung cancer Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours Year: 2015
Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015
Adenylate cyclase-associated protein 1 is associated with metastasis of non-small cell lung cancer especially in brain metastasis patients and promotes the lung cancer cell proliferation and migration in vitro as well as its growth and metastasis in vivo by the signaling pathways of limk1-cofilin Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours Year: 2015
Simvastatin overcomes gefitinib resistance in non-small cell lung cancer with the T790M mutation of epidermal growth factor receptor via Akt/b-catenin signaling dependent down-regulation of survivin Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013
Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015
Investigate which PKC isoform play an important role in human lung cancer cells against TRAIL-induced apoptosis Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013
RBM5 overexpression reverses acquired resistance to gefitinib in PC9/AB2 NSCLC cells Source: International Congress 2016 – Late-breaking translational research in lung cancer Year: 2016
ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumour metastasis Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016
Translocation of beta-catenin into cytoplasm during TGFbeta-induced EMT is negatively regulated by phosphorylation of the PTEN C-terminus in lung cancers Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013
Late Breaking Abstract: Effect of the hedgehog pathway inhibitor GDC-0449 on side populations in lung cancer cell lines Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010
Targeting Tryptophan metabolism pathway as a therapeutic strategy for non-small cell lung cancer Source: International Congress 2019 – Biology of lung cancer Year: 2019
Glucocorticoid reduces pemetrexed sensitivity by mediating senescence-associated secretory phenotype in Bcl-2 dependent manner in non-small-cell lung cancer Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013
Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016
Enhanced FGFR signaling correlates with erlotinib/bevacizumab response in advanced non-squamous non-small cell lung cancer Source: International Congress 2015 – Advances in the therapy of lung cancer Year: 2015
Novel two mechanisms for acquired EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutation Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014
Immunoglobulin-like transcripts 3 (ILT3) expression in human lung adenocarcinoma as a novel regulator of intratumoral lymphoid follicle formation Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015
Aromatase inhibition alters the mechanical properties of non small-cell lung cancer cells affecting cell movement Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013
Functional expressions of EGFP/LKB1 and its kinase domain induced apoptosis and enhanced chemosensitivity in lung cancer cell lines Source: Eur Respir J 2004; 24: Suppl. 48, 5s Year: 2004
Epidermal growth factor receptor (EGFR) expression in non-small cell lung carcinoma (NSCLC) and survival Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015
Salinomycin suppresses TGF-ß1-induced EMT by down-regulating MMP-2,9 via AMPK-SIRT1 pathway in a non-small cell lung cancer Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017